Haha so even worse for ALA, they're the less advanced of the two in the NK space.
I could imagine PH taking some heat from his fellow ALA directors. Almost as if he liked what he found in his DD of iNKT and decided to find a better prospect for CHM.
I know that's not how it is, as CHM has hinted at NK cells in the past. But still, poor ALA.
CHM Price at posting:
26.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)